134 related articles for article (PubMed ID: 7025545)
1. Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
Sonino N; Levine LS; New MI
Acta Endocrinol (Copenh); 1981 Sep; 98(1):87-94. PubMed ID: 7025545
[TBL] [Abstract][Full Text] [Related]
2. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
New MI; Peterson RE; Saenger P; Levine LS
J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
[TBL] [Abstract][Full Text] [Related]
4. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
6. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
[TBL] [Abstract][Full Text] [Related]
7. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
[TBL] [Abstract][Full Text] [Related]
8. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
[TBL] [Abstract][Full Text] [Related]
10. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-suppressible hyperaldosteronism.
New MI; Siegal EJ; Peterson RE
J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
[No Abstract] [Full Text] [Related]
12. Mineralocorticoid hypertension in childhood.
New MI; Levine LS
Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
[TBL] [Abstract][Full Text] [Related]
13. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Grim CE; Weinberger MH
Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
[TBL] [Abstract][Full Text] [Related]
14. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
16. Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
Haruyama K; Yamazaki M; Toki T; Fukuchi S
Jpn Circ J; 1982 Feb; 46(2):156-61. PubMed ID: 6276583
[TBL] [Abstract][Full Text] [Related]
17. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
20. Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension.
Padfield PL; Allison ME; Brown JJ; Ferriss JB; Fraser R; Lever AF; Luke RG; Robertson JI
Clin Endocrinol (Oxf); 1975 Sep; 4(5):493-500. PubMed ID: 1175311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
